Zhejiang Starry Pharmaceutical Co.,Ltd.’s Net Profit Rose 35.5% in First Three Quarters of 2023

Zhejiang Starry Pharmaceutical Co.,Ltd. (浙江司太立制药股份有限公司) (603520.SH) reported a net profit of 39.5 million yuan in the first three quarters of 2023, up 35.5% year-on-year.

Meanwhile, the company posted 1.6 billion yuan in revenue, up 18.4% year-on-year.

At the end of the reporting period, it had 5.7 billion yuan in total assets and 3.9 billion yuan in total liabilities, with a liability-to-asset ratio of 69.1%.